SELECT MEDICAL HOLDINGS CORP (SEM) Stock Fundamental Analysis

NYSE:SEM • US81619Q1058

14.91 USD
+0.01 (+0.07%)
Last: Feb 26, 2026, 11:21 AM
Fundamental Rating

5

SEM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While SEM is still in line with the averages on profitability rating, there are concerns on its financial health. SEM scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • SEM had positive earnings in the past year.
  • SEM had a positive operating cash flow in the past year.
  • In the past 5 years SEM has always been profitable.
  • In the past 5 years SEM always reported a positive cash flow from operatings.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • With a decent Return On Assets value of 2.44%, SEM is doing good in the industry, outperforming 60.40% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 8.38%, SEM is in the better half of the industry, outperforming 68.32% of the companies in the same industry.
  • SEM has a Return On Invested Capital (5.27%) which is in line with its industry peers.
  • SEM had an Average Return On Invested Capital over the past 3 years of 4.28%. This is below the industry average of 8.93%.
  • The last Return On Invested Capital (5.27%) for SEM is above the 3 year average (4.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROIC 5.27%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SEM's Profit Margin of 2.62% is fine compared to the rest of the industry. SEM outperforms 63.37% of its industry peers.
  • SEM's Profit Margin has declined in the last couple of years.
  • The Operating Margin of SEM (6.17%) is better than 69.31% of its industry peers.
  • In the last couple of years the Operating Margin of SEM has declined.
  • The Gross Margin of SEM (11.54%) is worse than 71.29% of its industry peers.
  • SEM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SEM is destroying value.
  • SEM has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SEM has less shares outstanding
  • Compared to 1 year ago, SEM has a worse debt to assets ratio.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.60, we must say that SEM is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.60, SEM perfoms like the industry average, outperforming 42.57% of the companies in the same industry.
  • The Debt to FCF ratio of SEM is 15.74, which is on the high side as it means it would take SEM, 15.74 years of fcf income to pay off all of its debts.
  • SEM's Debt to FCF ratio of 15.74 is in line compared to the rest of the industry. SEM outperforms 42.57% of its industry peers.
  • A Debt/Equity ratio of 1.07 is on the high side and indicates that SEM has dependencies on debt financing.
  • The Debt to Equity ratio of SEM (1.07) is worse than 62.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Altman-Z 1.6
ROIC/WACC0.55
WACC9.51%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.04 indicates that SEM should not have too much problems paying its short term obligations.
  • The Current ratio of SEM (1.04) is worse than 67.33% of its industry peers.
  • A Quick Ratio of 1.04 indicates that SEM should not have too much problems paying its short term obligations.
  • SEM has a worse Quick ratio (1.04) than 60.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. Growth

3.1 Past

  • SEM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.30%.
  • SEM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.36% yearly.
  • The Revenue has been growing slightly by 5.12% in the past year.
  • The Revenue has been decreasing by -0.29% on average over the past years.
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.64% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, SEM will show a small growth in Revenue. The Revenue will grow by 4.74% on average per year.
EPS Next Y15.13%
EPS Next 2Y15.26%
EPS Next 3Y21.64%
EPS Next 5YN/A
Revenue Next Year4.33%
Revenue Next 2Y4.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.97, SEM is valued correctly.
  • 86.14% of the companies in the same industry are more expensive than SEM, based on the Price/Earnings ratio.
  • SEM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.05.
  • A Price/Forward Earnings ratio of 11.26 indicates a reasonable valuation of SEM.
  • 87.13% of the companies in the same industry are more expensive than SEM, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.03. SEM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.97
Fwd PE 11.26
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SEM is valued cheaper than 80.20% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SEM indicates a somewhat cheap valuation: SEM is cheaper than 76.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.75
EV/EBITDA 7.65
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SEM's earnings are expected to grow with 21.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.86
PEG (5Y)N/A
EPS Next 2Y15.26%
EPS Next 3Y21.64%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.69%, SEM has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.49, SEM pays a better dividend. On top of this SEM pays more dividend than 89.11% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, SEM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.69%

5.2 History

  • SEM has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • SEM pays out 21.99% of its income as dividend. This is a sustainable payout ratio.
DP21.99%
EPS Next 2Y15.26%
EPS Next 3Y21.64%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (2/26/2026, 11:21:06 AM)

14.91

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners82.91%
Inst Owner Change-3.76%
Ins Owners11.06%
Ins Owner Change0.26%
Market Cap1.85B
Revenue(TTM)5.45B
Net Income(TTM)142.92M
Analysts77.78
Price Target17.88 (19.92%)
Short Float %3.94%
Short Ratio4.91
Dividend
Industry RankSector Rank
Dividend Yield 1.69%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP21.99%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.41%
Min EPS beat(2)-31%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)11.24%
Min EPS beat(4)-31%
Max EPS beat(4)49.82%
EPS beat(8)3
Avg EPS beat(8)-11.03%
EPS beat(12)7
Avg EPS beat(12)-1.92%
EPS beat(16)8
Avg EPS beat(16)-6.67%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)1.43%
Max Revenue beat(2)1.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.37%
Revenue beat(12)8
Avg Revenue beat(12)-0.69%
Revenue beat(16)10
Avg Revenue beat(16)5.67%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 12.97
Fwd PE 11.26
P/S 0.34
P/FCF 15.75
P/OCF 5.33
P/B 1.08
P/tB N/A
EV/EBITDA 7.65
EPS(TTM)1.15
EY7.71%
EPS(NY)1.32
Fwd EY8.88%
FCF(TTM)0.95
FCFY6.35%
OCF(TTM)2.8
OCFY18.77%
SpS44.04
BVpS13.77
TBVpS-6.11
PEG (NY)0.86
PEG (5Y)N/A
Graham Number18.88
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROCE 6.91%
ROIC 5.27%
ROICexc 5.3%
ROICexgc 10.74%
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
FCFM 2.15%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
ROICexc(3y)4.32%
ROICexc(5y)4.74%
ROICexgc(3y)8.45%
ROICexgc(5y)10.81%
ROCE(3y)5.62%
ROCE(5y)6.16%
ROICexgc growth 3Y36.24%
ROICexgc growth 5Y-11.26%
ROICexc growth 3Y45.51%
ROICexc growth 5Y-3.96%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Debt/EBITDA 3.82
Cap/Depr 163.38%
Cap/Sales 4.2%
Interest Coverage 2.79
Cash Conversion 72.71%
Profit Quality 82.03%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 1.6
F-Score5
WACC9.51%
ROIC/WACC0.55
Cap/Depr(3y)127.38%
Cap/Depr(5y)112.75%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.06%
Profit Quality(3y)122.64%
Profit Quality(5y)96.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
EPS Next Y15.13%
EPS Next 2Y15.26%
EPS Next 3Y21.64%
EPS Next 5YN/A
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%
Revenue Next Year4.33%
Revenue Next 2Y4.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.29%
EBIT growth 3Y32.43%
EBIT growth 5Y-6.78%
EBIT Next Year43.55%
EBIT Next 3Y18.69%
EBIT Next 5YN/A
FCF growth 1Y-60.35%
FCF growth 3Y7.47%
FCF growth 5Y-33.2%
OCF growth 1Y-33.1%
OCF growth 3Y6.75%
OCF growth 5Y-19.55%

SELECT MEDICAL HOLDINGS CORP / SEM FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 5 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 7 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Undervalued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 12.97 and the Price/Book (PB) ratio is 1.08.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 3 / 10.